Results 61 to 70 of about 39,205 (144)

Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report

open access: yesBMC Cancer, 2019
Background Patients with relapsed/refractory acute myeloid leukemia after hematopoietic stem cell transplantation (HSCT) have a poor prognosis, with a 2-year survival rate of 14%. The optimal treatment for these patients remains unclear.
Mengqi Jin   +9 more
doaj   +1 more source

PB2467: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 39 PATIENTS WITH NON-HODGKIN LYMPHOMA: LONG-TERM FOLLOW-UP IN A SINGLE CENTRE

open access: yesHemaSphere, 2023
Fouzia Louar   +11 more
doaj   +1 more source

Simultaneous Magnetic Particle Imaging and Navigation of large superparamagnetic nanoparticles in bifurcation flow experiments [PDF]

open access: yesarXiv, 2019
Magnetic Particle Imaging (MPI) has been successfully used to visualize the distribution of superparamagnetic nanoparticles within 3D volumes with high sensitivity in real time. Since the magnetic field topology of MPI scanners is well suited for applying magnetic forces on particles and micron-sized ferromagnetic devices, MPI has been recently used to
arxiv  

Haematopoietic Chimera in Man After Allogenic (Homologous) Bone-marrow Transplantation [PDF]

open access: green, 1963
G Mathé   +4 more
openalex   +1 more source

MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-Fos and JunB

open access: yesSignal Transduction and Targeted Therapy
Clinical evidence supports the notion that T cell exhaustion and terminal differentiation pose challenges to the persistence and effectiveness of chimeric antigen receptor-T (CAR-T) cells. MEK1/2 inhibitors (MEKIs), widely used in cancer treatment due to
Xiujian Wang   +27 more
doaj   +1 more source

A Topological Gaussian Mixture Model for Bone Marrow Morphology in Leukaemia [PDF]

open access: yesarXiv
Acute myeloid leukaemia (AML) is a type of blood and bone marrow cancer characterized by the proliferation of abnormal clonal haematopoietic cells in the bone marrow leading to bone marrow failure. Over the course of the disease, angiogenic factors released by leukaemic cells drastically alter the bone marrow vascular niches resulting in observable ...
arxiv  

Home - About - Disclaimer - Privacy